Company: GNMSF
Filing Date: 2025-02-12
Form Type: 20-F
Source: 0001558370-25-000846
Chunk: 23

Company: GENMAB A/S
Filing Date: 2025-02-12
Form: 20-F
Item: Item 4I
Chunk 23
---
ITEM 4INFORMATION ON THE COMPANY
A.   History and Development of the Company
We were incorporated on June 11, 1998, as a private limited liability company (“Anpartsselskab”, or “ApS”) under Danish law as a shelf company and are registered with the Danish Business Authority (Erhvervsstyrelsen) in Copenhagen, Denmark under registration number (CVR) no. 21023884. Our name was changed to Genmab ApS on November 17, 1998, and we commenced operations in February 1999. On May 31, 1999, we were converted into a public limited liability company (“Aktieselskab”, or “A/S”) and changed our name to Genmab A/S.
Our shares are listed on Nasdaq Copenhagen under the symbol “GMAB.” Our ADSs are listed on the NASDAQ in the U.S. under the symbol “GMAB.”

                      ​                         ​                                                     ​                                                   
----------------------------------------------------------------------------------------------------------------------------------------------------------
Legal name:                                         Genmab A/S                                                                                            
Commercial name:                                ​   Genmab                                                                                                
Domicile:                                       ​   Carl Jacobsens Vej 30, 2500 Valby, Denmark                                                            
Tel:                                            ​   +45 70 20 27 28                                                                                       
Website:                                        ​   www.genmab.com                                                                                        
​                                               ​   (The contents of this website are not incorporated by reference into this Annual Report on Form 20-F.)
Date of incorporation:                          ​   June 11, 1998                                                                                         
Legal form of the Company:                      ​   A Danish public limited liability company                                                             
Legislation under which the Company operates:   ​   Danish law                                                                                            
Country of incorporation:                       ​   Denmark                                                                                               
​
The SEC maintains an Internet site at www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.
For a description of our acquisition of ProfoundBio Inc. (“ProfoundBio”), please refer to “Item 5.A—Operating Results.”
​
B.    Business Overview
Overview
We are an international biotechnology company with a pipeline of novel antibody-based products and product candidates designed to address unmet medical needs and improve treatment outcomes for patients with cancer and other serious diseases. Our goal in building our pipeline is to bring medicines to market ourselves in geographic areas where we believe we will be able to maximize their value. 
​
Our current priorities